SUN Pharmaceutical Industries Limited Hydrochlorothiazide Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Hydrochlorothiazide Export Records India — #12 Exporter, 177 Shipments, $3.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Hydrochlorothiazide

India Pharmaceutical Trade Intelligence

$406.8M403 Suppliers149 CountriesHS 30049079

ExportsIndia → UNITED STATES63.6%India → CANADA14.9%

ImportsISRAEL → India$15.4M ITALY → India$69.2K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

SUN Pharmaceutical Industries Limited — Hydrochlorothiazide Exporter #12 | $3.4M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Hydrochlorothiazide Exporter Profile

Indian Pharmaceutical Exporter · #12 for Hydrochlorothiazide · $3.4M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #12 Indian exporter of Hydrochlorothiazide with $3.4M in export value and 177 verified shipments. SUN Pharmaceutical Industries Limited holds a 1.0% market share in Hydrochlorothiazide exports across 7 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Hydrochlorothiazide Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Hydrochlorothiazide export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Hydrochlorothiazide?

Country	Value	Shipments	Share
CANADA	$1.2M	70	40.8%
BELGIUM	$1.2M	73	38.8%
TANZANIA	$313.7K	9	10.3%
KENYA	$164.2K	6	5.4%
BRAZIL

Who Are the Top Buyers of Hydrochlorothiazide from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.1M	70
SUN PHARMA CANADA INC	CANADA	$601.5K	24
SUN PHARMA CANADA INC.,	CANADA	$220.0K	21
SUN PHARMA CANADA LNC	CANADA	$194.8K	14
TO THE ORDER OF ECOBANK TANZANIA	TANZANIA	$100.0K	2
M S SUN PHARMA CANADA INC	CANADA	$90.1K	3
M/S. SUN PHARMA CANADA INC	CANADA	$81.2K	5
SUN PHARMA EAST AFRICA LIMITED, T40	KENYA	$55.8K	3
BANK OF AFRICA TANZANIA LTD	TANZANIA	$50.0K	1
MS SUN PHARMA EAST AFRICA LIMITED	KENYA	$50.0K	1

SUN Pharmaceutical Industries Limited supplies Hydrochlorothiazide to 35 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by SUN PHARMA CANADA INC (CANADA) and SUN PHARMA CANADA INC., (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Hydrochlorothiazide Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS	$378.7K	15
IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 3	$226.2K	8
IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 300+12.5MG ( IRBES+COMP BASICS TAB 300+12.5MG ) EACH FILM COATED TABLET CONTAINS:	$82.2K	5
IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 1	$78.8K	5
RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS5+12.5MG (TARO RAMIPRIL+HCTZ TAB 5+12.5MG)EACH TABLETCONTIANS**NOS	$73.8K	6
RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS10 12 5MG TARO RAMIPRIL HCTZ RXY TAB 10 12 5MG PACK 100s Bottl Batch PTD5	$53.6K	2
RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS10+12.5MG (TARO-RAMIPRIL+HCTZ RXY TAB 10+12.5MG) EACH TABLET CONTAINS: ****	$53.3K	3
IRBESARTAN+HYDROCHLOROTHIAZIDE TABLETS 300+25MG ( IRBES+COMP BASICS TAB 300+25MG) EACH FILM COATED TABLET CONTAINS: IRB	$50.4K	3
IROVEL H TABLETS IRBESARTAN 150 MG ANDHYDROCHLOROTHIAZIDE 12.5 MG TABLETS PACK: Box3x10s	$50.0K	1
RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS5+25MG ( RAMIPRIL HCTZ SUN TAB 5+25MG )EACH TABLET CONTAINS:RAMIPRIL PH.EUR 5M	$50.0K	1

SUN Pharmaceutical Industries Limited exports 107 distinct Hydrochlorothiazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RAMIPRIL AND HYDROCHLOROTHIAZIDE TABLETS with 15 shipments worth $378.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Hydrochlorothiazide Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	MACLEODS PHARMACEUTICALS LIMITED	$3.9M	188	21	$20.9K
9	CAPLIN POINT LABORATORIES LIMITED	$3.5M	69	6	$50.0K
12	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$3.4M	177	7	$19.3K
13	AUROBINDO PHARMA LTD	$3.2M	391	8	$8.3K
14	TORRENT PHARMACEUTICALS LTD	$3.1M	110	8	$28.4K

SUN Pharmaceutical Industries Limited ranks #12 among 403 Indian Hydrochlorothiazide exporters. Average shipment value of $19.3K compared to the market average of $295.9K. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and CAPLIN POINT LABORATORIES LIMITED.

Which Indian Ports Ship Hydrochlorothiazide Exports?

Port	Shipments	% Share
SAHAR AIR	1,041	15.0%
SAHAR AIR CARGO ACC (INBOM4)	621	8.9%
NHAVA SHEVA SEA (INNSA1)	621	8.9%
JNPT/ NHAVA SHEVA SEA	493	7.1%
DELHI AIR	319	4.6%
JNPT	312	4.5%
Bombay Air	252	3.6%
HYDERABAD ICD	210	3.0%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Hydrochlorothiazide Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Hydrochlorothiazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 186 individual customs records matching SUN Pharmaceutical Industries Limited exporting Hydrochlorothiazide, covering 107 formulations to 9 countries via 35 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 149+ countries, 1,130+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Hydrochlorothiazide

Hydrochlorothiazide

SUN Pharmaceutical Industries Limited — Hydrochlorothiazide Exporter Profile

SUN Pharmaceutical Industries Limited — Hydrochlorothiazide Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Hydrochlorothiazide?

Who Are the Top Buyers of Hydrochlorothiazide from SUN Pharmaceutical Industries Limited?

What Is India's Total Hydrochlorothiazide Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Hydrochlorothiazide Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Hydrochlorothiazide Exporters?

What Hydrochlorothiazide Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Hydrochlorothiazide to Key Markets

Canada — HC

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Hydrochlorothiazide Exporters?

Which Indian Ports Ship Hydrochlorothiazide Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Hydrochlorothiazide Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Hydrochlorothiazide Export Data from SUN Pharmaceutical Industries Limited

Hydrochlorothiazide Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source